Management of Retinitis Pigmentosa Via Wharton′s JellyDerived Mesenchymal Stem Cells or Combination With Magnovision: 3-Year Prospective Results

ÖZMERT E., Arslan U.

STEM CELLS TRANSLATIONAL MEDICINE, cilt.12, ss.631-650, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 12
  • Basım Tarihi: 2023
  • Doi Numarası: 10.1093/stcltm/szad051
  • Dergi Adı: STEM CELLS TRANSLATIONAL MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, MEDLINE, Directory of Open Access Journals
  • Sayfa Sayıları: ss.631-650
  • Anahtar Kelimeler: retinitis pigmentosa, stemcell, Wharton jelly, umbilical cord, mesenchymal stemcell, electromagnetic stimulation, iontophoresis, Magnovision, ELECTROMAGNETIC-FIELD EXPOSURE, EXTRACELLULAR VESICLES, FUNDUS AUTOFLUORESCENCE, AUTOSOMAL-DOMINANT, STIMULATION, PROLIFERATION, CHANNELS, SAFETY, ROD, TMS
  • Ankara Üniversitesi Adresli: Evet

Özet

To investigate whether the natural progression rate of retinitis pigmentosa (RP) can be decreased with subtenon Wharton ' s jelly-derived mesenchymal stem cell (WJ-MSC) application alone or combination with Magnovision.